LXEO fund manager activity
Lexeo Therapeutics, Inc · Nasdaq. Reported by 2 tracked fund managers in their 13F filings, Q4 2023 to Q2 2026.
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Dan Sundheim - D1 Capital Partners | No change | 978,652 | $6,498,249 | 0.07% | Nov 14, 2025 |
Q2 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Dan Sundheim - D1 Capital Partners | No change | 978,652 | $3,934,181 | 0.05% | Aug 14, 2025 |